367 related articles for article (PubMed ID: 23850064)
21. Papilledema: A review of etiology, pathophysiology, diagnosis, and management.
Xie JS; Donaldson L; Margolin E
Surv Ophthalmol; 2022; 67(4):1135-1159. PubMed ID: 34813854
[TBL] [Abstract][Full Text] [Related]
22. Optic nerve sheath decompression for visual loss in intracranial hypertension: report from a tertiary care center in South India.
Nithyanandam S; Manayath GJ; Battu RR
Indian J Ophthalmol; 2008; 56(2):115-20. PubMed ID: 18292621
[TBL] [Abstract][Full Text] [Related]
23. Asymmetric papilledema in idiopathic intracranial hypertension.
Bidot S; Bruce BB; Saindane AM; Newman NJ; Biousse V
J Neuroophthalmol; 2015 Mar; 35(1):31-6. PubMed ID: 25494197
[TBL] [Abstract][Full Text] [Related]
24. Presumptive Idiopathic Intracranial Hypertension Based on Neuroimaging Findings: A Referral Pattern Study.
Aung AB; Chen BS; Wicks J; Bruce BB; Meyer BI; Dattilo M; Kedar S; Saindane A; Newman NJ; Biousse V
J Neuroophthalmol; 2023 Mar; 43(1):55-62. PubMed ID: 36166790
[TBL] [Abstract][Full Text] [Related]
25. Benign intracranial hypertension: visual loss and optic nerve sheath fenestration.
Knight RS; Fielder AR; Firth JL
J Neurol Neurosurg Psychiatry; 1986 Mar; 49(3):243-50. PubMed ID: 3958737
[TBL] [Abstract][Full Text] [Related]
26. External lumbar drainage in progressive pediatric idiopathic intracranial hypertension.
Dotan G; Hadar Cohen N; Qureshi HM; Shapira Rootman M; Nevo Y; Kershenovich A
J Neurosurg Pediatr; 2021 Jul; 28(4):490-496. PubMed ID: 34271543
[TBL] [Abstract][Full Text] [Related]
27. Complications of Optic Nerve Sheath Fenestration as a Treatment for Idiopathic Intracranial Hypertension.
Gilbert AL; Chwalisz B; Mallery R
Semin Ophthalmol; 2018; 33(1):36-41. PubMed ID: 29420144
[TBL] [Abstract][Full Text] [Related]
28. Unilateral and highly asymmetric papilledema in pseudotumor cerebri.
Lepore FE
Neurology; 1992 Mar; 42(3 Pt 1):676-8. PubMed ID: 1549237
[TBL] [Abstract][Full Text] [Related]
29. Enhancement of optic nerve sheath on MRI in idiopathic intracranial hypertension(IIH).
Ma Z; Jiang H; Wang J
Clin Neurol Neurosurg; 2023 Aug; 231():107778. PubMed ID: 37348315
[TBL] [Abstract][Full Text] [Related]
30. Perimetry, retinal nerve fiber layer thickness and papilledema grade after cerebrospinal fluid shunting in patients with idiopathic intracranial hypertension.
Rizzo JL; Lam KV; Wall M; Wilson MD; Keltner JL
J Neuroophthalmol; 2015 Mar; 35(1):22-5. PubMed ID: 25295682
[TBL] [Abstract][Full Text] [Related]
31. Using Optical Coherence Tomography as a Surrogate of Measurements of Intracranial Pressure in Idiopathic Intracranial Hypertension.
Vijay V; Mollan SP; Mitchell JL; Bilton E; Alimajstorovic Z; Markey KA; Fong A; Walker JK; Lyons HS; Yiangou A; Tsermoulas G; Brock K; Sinclair AJ
JAMA Ophthalmol; 2020 Dec; 138(12):1264-1271. PubMed ID: 33090189
[TBL] [Abstract][Full Text] [Related]
32. Detection of nerve fiber atrophy in apparently effectively treated papilledema in idiopathic intracranial hypertension.
Laemmer R; Heckmann JG; Mardin CY; Schwab S; Laemmer AB
Graefes Arch Clin Exp Ophthalmol; 2010 Dec; 248(12):1787-93. PubMed ID: 20677009
[TBL] [Abstract][Full Text] [Related]
33. Utility of Intracranial Pressure Monitoring for Diagnosis of Idiopathic Intracranial Hypertension in the Absence of Papilledema.
Bridges KJ; Raslan AM
World Neurosurg; 2018 Mar; 111():e221-e227. PubMed ID: 29258930
[TBL] [Abstract][Full Text] [Related]
34. Brain Imaging in Idiopathic Intracranial Hypertension.
Bidot S; Saindane AM; Peragallo JH; Bruce BB; Newman NJ; Biousse V
J Neuroophthalmol; 2015 Dec; 35(4):400-11. PubMed ID: 26457687
[TBL] [Abstract][Full Text] [Related]
35. Magnetic Resonance Imaging Findings in Pediatric Pseudotumor Cerebri Syndrome.
Kohli AA; Vossough A; Mallery RM; Woo JH; Sheldon CA; Paley GL; Digre KB; Friedman DI; Farrar JT; McCormack SE; Liu GT; Szperka CL
Pediatr Neurol; 2019 Oct; 99():31-39. PubMed ID: 31303369
[TBL] [Abstract][Full Text] [Related]
36. Optic nerve diameters and perimetric thresholds in idiopathic intracranial hypertension.
Salgarello T; Tamburrelli C; Falsini B; Giudiceandrea A; Colotto A
Br J Ophthalmol; 1996 Jun; 80(6):509-14. PubMed ID: 8759260
[TBL] [Abstract][Full Text] [Related]
37. Undiagnosed papilledema in a morbidly obese patient population: a prospective study.
Krispel CM; Keltner JL; Smith W; Chu DG; Ali MR
J Neuroophthalmol; 2011 Dec; 31(4):310-5. PubMed ID: 21799447
[TBL] [Abstract][Full Text] [Related]
38. Optic nerve appearance as a predictor of visual outcome in patients with idiopathic intracranial hypertension.
Micieli JA; Bruce BB; Vasseneix C; Blanch RJ; Berezovsky DE; Peragallo JH; Newman NJ; Biousse V
Br J Ophthalmol; 2019 Oct; 103(10):1429-1435. PubMed ID: 30530819
[TBL] [Abstract][Full Text] [Related]
39. Venous Sinus Stenting in Idiopathic Intracranial Hypertension: Results of a Prospective Trial.
Dinkin MJ; Patsalides A
J Neuroophthalmol; 2017 Jun; 37(2):113-121. PubMed ID: 27556959
[TBL] [Abstract][Full Text] [Related]
40. Etiology of Papilledema in Patients in the Eye Clinic Setting.
Crum OM; Kilgore KP; Sharma R; Lee MS; Spiegel MR; McClelland CM; Bhatti MT; Chen JJ
JAMA Netw Open; 2020 Jun; 3(6):e206625. PubMed ID: 32484553
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
